RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $754,907 | -39.6% | 89,763 | -9.7% | 0.00% | -50.0% |
| Q2 2023 | $1,249,029 | -24.7% | 99,445 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $1,658,562 | +8.9% | 100,702 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $1,523,492 | -30.1% | 101,974 | +4.8% | 0.00% | -50.0% |
| Q3 2022 | $2,178,000 | +47.7% | 97,342 | +10.6% | 0.00% | +100.0% |
| Q2 2022 | $1,475,000 | -26.2% | 88,031 | +31.9% | 0.00% | -33.3% |
| Q1 2022 | $1,998,000 | -12.0% | 66,758 | -9.7% | 0.00% | 0.0% |
| Q4 2021 | $2,270,000 | +22.4% | 73,904 | +25.6% | 0.00% | +50.0% |
| Q3 2021 | $1,855,000 | -37.2% | 58,843 | -27.1% | 0.00% | -50.0% |
| Q2 2021 | $2,953,000 | +23.5% | 80,693 | +16.7% | 0.00% | +33.3% |
| Q1 2021 | $2,391,000 | +18.1% | 69,165 | +42.0% | 0.00% | 0.0% |
| Q4 2020 | $2,024,000 | -2.4% | 48,708 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,074,000 | – | 48,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |